Insite Vision Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Insite Vision Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: steve dowling who wrote (783)	7/10/1998 8:17:00 PM
From: Robert Mayo	Read Replies (1) of 1060

Steve, I didn't ask about Kumar's itinerary. Yes, it is the same old story. And, yes, the stock price sucks. I keep telling myself I ought to unload ISV and move on. But I just can't do it. The "story" remains good and the company is grotesquely undervalued. If it ever does get those deals put together, and ISV-900 to market, the royalty $$$ should be considerable. Unfortunately, the stock price/market cap is so low that most institutions simply aren't interested. One consequence of that is that there's no up-to-date analysis out there except CTSL, a highly controversial source these days. Analysts aren't going to waist any time on ISV until the stock price moves (and stays) above $5 at least. September will mark my third year holding this stock. Lots of lost opportunities over those years having my dollars tied-up in this one. Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next